What were Stepan Company's adjusted earnings per share and revenue for Q2 2026, and how did they compare to expectations and prior-year results?

Stepan Company reported adjusted earnings of $1.18 per share for Q2 2026, significantly exceeding the Wall Street consensus of $0.62 per share. Its revenue reached $684.1 million, representing a 15.0% year-over-year increase, driven by strong organic sales volume growth of 6.0% and robust performance in its surfactants division.

Why did Stepan Company's Q2 2026 financial results stand out to analysts, and what factors supported their continued positive stance on the stock?

Analysts maintained a positive stance on Stepan Company's stock due to the company's improved margins and operational execution, as reflected in its Q2 2026 results—specifically, the substantial beat on adjusted earnings per share ($1.18 vs. $0.62 consensus) and strong 15.0% year-over-year revenue growth to $684.1 million, fueled by 6.0% organic sales volume growth and standout performance in the surfactants division.